Behcet's disease

被引:30
作者
Davatchi, Fereydoun [1 ,2 ,3 ,4 ]
机构
[1] Univ Tehran Med Sci, Div Rheumatol, Tehran, Iran
[2] Univ Tehran Med Sci, Rheumatol Res Ctr, Tehran, Iran
[3] Iranian Rheumatol Assoc, Mashhad, Iran
[4] APLAR Special Interest Grp Behcets Dis, Tehran, Iran
关键词
KOREA;
D O I
10.1111/1756-185X.12378
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim This study was designed to evaluate iron deficiency as a predisposing factor for resistant oral aphthosis in patients with Behcet's disease (BD). Methods In a case control study 220 consecutive BD patients with oral aphthosis were enrolled. All patients had been treated for at least 3months. They were divided into two groups according to their treatment response (75 patients in the Case and 145 in the Control group). Demographic and clinical characteristics of the disease, serum iron, total iron binding capacity and serum ferritin were determined in each patient. We used independent t-test and Mann-Whitney U-test to compare the quantitative variables and chi-square test for qualitative variables. Odds ratio (OR) and confidence interval at 95% (95% CI) were calculated for each item. Results There was no significant difference between the two groups in demographics or clinical characteristics of the disease. We found iron deficiency in 72 patients (32.7%, 95% CI: 6.2), higher in the Case group than Control (39.2% vs. 30.1%; P=0.17). Despite the higher frequency of iron deficiency in men (26.8% vs. 14.5%), the difference was not statistically significant (P=0.09). Multivariate logistic regression analysis showed that none of the iron deficiency or sex variables could predict the development of resistant oral aphthosis. The OR for iron deficiency was 1.52 (95% CI: 0.81-2.86) and for male sex was 1.04 (95% CI: 0.56-1.91). Conclusion Despite the higher frequency of iron deficiency in BD patients with resistant oral aphthosis, we were not able to attribute this resistance to this deficiency.
引用
收藏
页码:355 / 357
页数:3
相关论文
共 16 条
[1]   Mevalonate kinase gene mutations and their clinical correlations in Behcet's disease [J].
Arslan Tas, Didem ;
Erken, Eren ;
Yildiz, Fatih ;
Dinkci, Suzan ;
Sakalli, Hakan .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (04) :435-443
[2]   Epidemiologic and clinical survey of Behcet's disease in Korea: the first multicenter study [J].
Bang, D ;
Lee, JH ;
Lee, ES ;
Lee, S ;
Choi, JS ;
Kim, YK ;
Cho, BK ;
Koh, JK ;
Won, YH ;
Kim, NI ;
Park, SD ;
Ahn, HJ ;
Lee, YW ;
Wang, HY ;
Lee, WW ;
Eun, HC ;
Song, ES ;
Lee, SW ;
Lee, CW ;
Lee, CJ ;
Park, JH ;
Song, YW ;
Kim, ST ;
Kim, CY ;
Park, JK ;
Kwon, KS .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2001, 16 (05) :615-618
[3]   The International Criteria for Behcet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria [J].
Davatchi, F. ;
Assaad-Khalil, S. ;
Calamia, K. T. ;
Crook, J. E. ;
Sadeghi-Abdollahi, B. ;
Schirmer, M. ;
Tzellos, T. ;
Zouboulis, C. C. ;
Akhlagi, M. ;
Al-Dalaan, A. ;
Alekberova, Z. S. ;
Ali, A. A. ;
Altenburg, A. ;
Arromdee, E. ;
Baltaci, M. ;
Bastos, M. ;
Benamour, S. ;
Ben Ghorbel, I. ;
Boyvat, A. ;
Carvalho, L. ;
Chen, W. ;
Ben-Chetrit, E. ;
Chams-Davatchi, C. ;
Correia, J. A. ;
Crespo, J. ;
Dias, C. ;
Dong, Y. ;
Paixao-Duarte, F. ;
Elmuntaser, K. ;
Elonakov, A. V. ;
Grana Gil, J. ;
Haghdoost, A-A. ;
Hayani, R. M. ;
Houman, H. ;
Isayeva, A. R. ;
Jamshidi, A. R. ;
Kaklamanis, P. ;
Kumar, A. ;
Kyrgidis, A. ;
Madanat, W. ;
Nadji, A. ;
Namba, K. ;
Ohno, S. ;
Olivieri, I. ;
Vaz Patto, J. ;
Pipitone, N. ;
de Queiroz, M. V. ;
Ramos, F. ;
Resende, C. ;
Rosa, C. M. .
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (03) :338-347
[4]   Combination of pulse cyclophosphamide and azathioprine in ocular manifestations of Behcet's disease: longitudinal study of up to 10years [J].
Davatchi, Fereydoun ;
Sadeghi Abdollahi, Bahar ;
Shams, Hormoz ;
Shahram, Farhad ;
Nadji, Abdolhadi ;
Chams-Davatchi, Cheyda ;
Faezi, Tahereh ;
Akhlaghi, Massoomeh ;
Ghodsi, Zahra ;
Ashofteh, Farimah ;
Mohtasham, Negin .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (04) :444-452
[5]   Mesenchymal stem cell therapy unable to rescue the vision from advanced Behcet's disease retinal vasculitis: report of three patients [J].
Davatchi, Fereydoun ;
Nikbin, Behrooz ;
Shams, Hormoz ;
Sadeghi Abdollahi, Bahar ;
Mohyeddin, Mandana ;
Shahram, Farhad .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2013, 16 (02) :139-147
[6]   Behcet's disease: from east to west [J].
Davatchi, Fereydoun ;
Shahram, Farhad ;
Chams-Davatchi, Cheyda ;
Shams, Hormoz ;
Nadji, Abdolhadi ;
Akhlaghi, Massoomeh ;
Faezi, Tahereh ;
Ghodsi, Zahra ;
Faridar, Alireza ;
Ashofteh, Farima ;
Abdollahi, Bahar Sadeghi .
CLINICAL RHEUMATOLOGY, 2010, 29 (08) :823-833
[7]   How to deal with Behcet's disease in daily practice [J].
Davatchi, Fereydoun ;
Shahram, Farhad ;
Chams-Davatchi, Cheyda ;
Shams, Hormoz ;
Nadji, Abdolhadi ;
Akhlaghi, Massoomeh ;
Faezi, Tahereh ;
Abdollahi, Bahar Sadeghi .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2010, 13 (02) :105-116
[8]  
Davatchi F, 2009, IRAN J OPHTHALMOL, V21, P3
[9]  
Dormohammadi Toosi T, 2014, INT J RHEUM DIS, V17, P425, DOI 10.1111/1756-185X.12045
[10]   The status of serum vitamin D in patients with active Behcet's disease compared with controls [J].
Khabbazi, Alireza ;
Rashtchizadeh, Nadereh ;
Ghorbanihaghjo, Amir ;
Hajialiloo, Mehrzad ;
Ghojazadeh, Mortasa ;
Taei, Ramin ;
Kolahi, Sousan .
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (04) :430-434